Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019:1148:81-103.
doi: 10.1007/978-981-13-7709-9_4.

X-Ray Crystallography in Structure-Function Characterization of Therapeutic Enzymes

Anastassios C Papageorgiou  1
Affiliations
Review

X-Ray Crystallography in Structure-Function Characterization of Therapeutic Enzymes

Anastassios C Papageorgiou. Adv Exp Med Biol. 2019.

Abstract

Enzymes are key biological macromolecules that support life by accelerating the conversion of target molecules to desired products in many biochemical reactions. Enzymes are characterized by high affinity, specificity and great catalytic efficiency. Owing to their unique characteristics, enzymes have attracted significant attention for use in therapeutic settings as a distinct class of drugs different from other types of medicines. Enzyme-based therapies are currently in use for the treatment of a wide range of diseases, including leukemia, metabolic disorders, inflammation and cardiovascular disease. However, several challenges, such as immunogenicity and stability, remain. X-ray crystallography has provided key structural insights into the understanding of the molecular basis of diseases and development of enzyme-based therapies. Here, the role of X-ray crystallography in the development of therapeutic enzymes is examined and several examples are provided.

Keywords: Chaperones; Enzyme deficiency; Enzyme stability; Enzyme therapy; Structure stabilizers.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Aviezer D, Brill-Almon E, Shaaltiel Y, Hashmueli S, Bartfeld D, Mizrachi S, Liberman Y, Freeman A, Zimran A, Galun E (2009) A plant-derived recombinant human glucocerebrosidase enzyme – a preclinical and phase I investigation. PLoS One 4:e4792. https://doi.org/10.1371/journal.pone.0004792 - DOI - PubMed - PMC
    1. Avramis VI (2011) Asparaginases: a successful class of drugs against leukemias and lymphomas. J Pediatr Hematol Oncol 33:573–579. https://doi.org/10.1097/MPH.0b013e31823313be - DOI - PubMed
    1. Bell SM, Wendt DJ, Zhang Y, Taylor TW, Long S, Tsuruda L, Zhao B, Laipis P, Fitzpatrick PA (2017) Formulation and PEGylation optimization of the therapeutic PEGylated phenylalanine ammonia lyase for the treatment of phenylketonuria. PLoS One 12:e0173269. https://doi.org/10.1371/journal.pone.0173269 - DOI - PubMed - PMC
    1. Benjwal S, Verma S, Röhm K-H, Gursky O (2006) Monitoring protein aggregation during thermal unfolding in circular dichroism experiments. Protein Sci 15:635–639. https://doi.org/10.1110/ps.051917406 - DOI - PubMed - PMC
    1. Bennett LL, Mohan D (2013) Gaucher disease and its treatment options. Ann Pharmacother 47:1182–1193. https://doi.org/10.1177/1060028013500469 - DOI - PubMed

MeSH terms

LinkOut - more resources